-
MLN4924: Designing Neddylation Mechanism Assays
2026-08-31
MLN4924 is a selective NEDD8-activating enzyme inhibitor for dissecting protein degradation, cell-cycle control, and treatment resistance. This article develops an assay-centered framework linking neddylation pathway inhibition with cyclin D3 turnover and trastuzumab resistance without assuming that every degradation phenotype is CRL-dependent.
-
Neomycin sulfate: Workflows for RNA/DNA Studies
2026-08-31
Neomycin sulfate is a water-soluble aminoglycoside antibiotic that converts nucleic-acid structure and ion-channel biology into experimentally tractable perturbations. This guide pairs practical assay workflows with controls for hammerhead ribozymes, Tat/TAR RNA, DNA triplexes, and ryanodine receptors while clearly separating established mechanisms from exploratory applications.
-
EdU Imaging Kits (488): Reliable S-Phase Data
2026-08-30
Learn how EdU Imaging Kits (488), SKU K1175, support reproducible S-phase DNA synthesis measurement in microscopy and flow cytometry workflows. This scenario-based guide addresses assay interpretation, immunofluorescence compatibility, protocol optimization, and practical product selection.
-
MRSA Extracellular Vesicles Drive OSCC via IL-8
2026-08-29
A 2026 study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus can promote oral squamous cell carcinoma through an ERK/c-Jun–IL-8–CXCR1 signaling circuit. The work links antibiotic resistance to tumor biology and identifies bacterial vesicle cargo, IL-8 loss, and CXCR1 blockade as experimentally useful points for mechanistic validation.
-
CD40–STING–TRAF2 Signaling in ESCC TLS
2026-08-28
A 2025 study in Cancer Gene Therapy links tertiary lymphoid structures with favorable survival in treatment-naïve esophageal squamous cell carcinoma and identifies IRF4-positive, tumor-infiltrating B cells as a central immune population. Its mechanistic data indicate that CD40 and STING compete for TRAF2, influencing non-canonical NF-κB signaling, STING post-translational regulation, and IRF4-mediated B cell activation.
-
Deferasirox for HCC Ferroptosis Research
2026-08-28
Deferasirox provides a practical way to perturb chelatable iron while connecting iron-overload biology with ferroptosis research in hepatocellular carcinoma. This guide translates the METTL16–SENP3–LTF findings into controlled cell, organoid, and translational assay workflows, with troubleshooting for solubility, oxygen, and endpoint interpretation.
-
CRISPR Live-Cell Imaging of Non-Repetitive Loci
2026-08-27
The reference study introduces CRISPR PRO-LiveFISH, a live-cell imaging strategy that combines orthogonal bases with rational sgRNA design to visualize multiple endogenous, non-repetitive genomic loci. By reducing guide requirements and avoiding signal amplification, the method enables analysis of enhancer–promoter dynamics, chromatin mobility, and epigenetic-state relationships in diverse cells, including primary cells.
-
Bifendate (DDB): A Translational Liver Strategy
2026-08-27
Bifendate (DDB) offers a mechanism-led framework for studying hepatoprotection, lipid metabolism, autophagy, and injury-associated molecular networks. This thought-leadership guide translates multiomics findings into practical experimental strategy while highlighting formulation, exposure, and CYP3A4-related considerations.
-
a-MSH, Amide for Pigmentation Research
2026-08-26
Use a-MSH, amide as a controlled melanocortin stimulus for reproducible melanin synthesis, receptor pharmacology, and pathway-validation experiments. This workflow pairs dose-response design with the CREB/MITF assay logic of a recent natural-product study, while separating pigmentation evidence from exploratory anti-inflammatory applications.
-
LY-411575: From Secretase Control to Translation
2026-08-26
A translational framework for using LY-411575 to connect amyloid biology, Notch signaling, and immune-oncology while separating mechanistic opportunity from pathway-wide risk.
-
C8-HSL and Lung Cancer: PI3K/AKT/ERK Evidence
2026-08-25
The reference study identifies the bacterial quorum-sensing molecule C8-HSL as a potential host-directed risk factor in lung cancer, linking it to H460 cell proliferation, migration, and invasion through PI3K/AKT/ERK signaling. Its findings provide an early mechanistic bridge between bacterial communication molecules and tumor behavior, while also highlighting the need for validation across models and in patient-derived systems.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-25
Build sensitive rabbit-primary detection into immunofluorescence, ICC, IHC, and flow cytometry workflows with a Cy3-conjugated secondary antibody. This guide translates a NETosis toxicology study into practical staining, multiplexing, quantification, and troubleshooting strategies without overstating what the reference study directly validated.
-
DAPI Nuclear Stain Solution: Lab Guide
2026-08-24
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and membrane-integrity assessment in fixed or membrane-compromised cells. It is intended for fluorescence microscopy and flow cytometry workflows, not as a default stain for intact live-cell imaging or as a standalone diagnostic apoptosis assay.
-
Carvedilol Phosphate in IRI Research
2026-08-24
Carvedilol Phosphate provides a controlled way to interrogate adrenergic GPCR signaling alongside hepatocyte–macrophage crosstalk in ischemia–reperfusion experiments. This workflow emphasizes formulation control, orthogonal readouts, and careful separation of established beta-blocker pharmacology from emerging Arrb2–6-ketoLCA hypotheses.
-
Cy3-UTP for Fluorescent RNA Labeling
2026-08-23
Cy3-UTP is a Cy3-modified uridine triphosphate for in vitro transcription RNA labeling. Its water solubility, reported 95% purity, brightness, and photostability support fluorescent RNA production for imaging, RNA-protein interaction studies, and RNA detection assays.